Continuous Positive Airway Pressure CPAP

DEVICE4 trials

Sponsors

Hospital de Granollers, University of British Columbia, Sharp HealthCare, Faculty of Medicine Menoufia University

Conditions

Neonatal DiseasesObstructive Sleep ApneaPremature LungsRespiratory Distress SyndromeSleep ApneaSurfactant Deficiency Syndrome NeonatalType 2 Diabetes

Early Phase 1

Improving 24-hour Blood Pressure in Obstructive Sleep Apnea

WithdrawnNCT04021550

University of British ColumbiaObstructive Sleep Apnea

Start: 2023-05-31End: 2026-12-31Updated: 2023-05-19

Unknown Phase

Evolution With CPAP Treatment of a Cohort of Type 2 Diabetic Patients With Apnea-hypopnea Syndrome

CompletedNCT01307566

Hospital de GranollersSleep Apnea, Type 2 Diabetes

Start: 2011-03-31End: 2015-01-31Updated: 2015-01-06

Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants

CompletedNCT04209946

Sharp HealthCarePremature Lungs, Respiratory Distress Syndrome, Surfactant Deficiency Syndrome Neonatal

Start: 2020-01-22End: 2025-11-10Updated: 2025-12-18

High Velocity Nasal Insufflation versus Continuous Positive Airway Pressure as an Initial Respiratory Support in Preterm Neonates with Respiratory Distress Syndrome: A Prospective Randomized Clinical Trial

Active, not recruitingPACTR202511465374837

Faculty of Medicine Menoufia UniversityNeonatal Diseases

Start: 2024-10-01Target: 300Updated: 2026-01-27

Related Papers

Caffeine and Less Invasive Surfactant Administration for Respiratory Distress Syndrome of the Newborn

NEJM Evidence2023-11-2119 citations

Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): study protocol

BMJ Open2021-01-0113 citations